Literature DB >> 30658167

History of detention and the risk of hepatitis C among people who inject drugs in Germany.

Martyna Gassowski1, Stine Nielsen2, Norbert Bannert3, Claus-Thomas Bock4, Viviane Bremer5, R Stefan Ross6, Benjamin Wenz7, Ulrich Marcus8, Ruth Zimmermann9.   

Abstract

OBJECTIVES: The aim of this study was to investigate the association between detention experience and hepatitis C virus (HCV) status, the role of duration and frequency of detention, and whether risk behaviours practiced in detention could explain an observed increase in risk.
METHODS: Current drug injectors (injecting in the last 12 months) were recruited to participate in a sero-behavioural, cross-sectional survey using respondent-driven sampling in eight German cities during the years 2011-2014. Using multivariable logistic regression, the association between HCV status and reported detention experience was investigated.
RESULTS: A total of 1998 participants were included in the analysis. Of these, 19.9% reported no detention experience, 28.6% short and rare experience (≤3.5 years in total, ≤3 times), 12.1% short but frequent experience, 7.1% long but rare experience, and 32.4% long and frequent experience. After correcting for HCV risk factors, the association between detention experience and HCV status remained statistically significant. By adjusting the model for intramural risk behaviours, the odds ratios of detention experience were reduced but remained significant.
CONCLUSIONS: The proportion of people who inject drugs positive for HCV increased with both frequency and duration of their detention experience. As intramural risk behaviours could not fully explain this increase, it appears that transfers between community and custody may confer additional risks.
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Detention; Germany; HCV; Incarceration; PWID; Prison

Mesh:

Year:  2019        PMID: 30658167     DOI: 10.1016/j.ijid.2019.01.015

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  3 in total

1.  HCV and HIV co-infection among people who inject drugs in Vietnam.

Authors:  Vu Toan Thinh; Li Li; Dréan Matthieu; Van Dinh Hoa; Nguyen Huu Anh; Le Minh Giang
Journal:  J Health Soc Sci       Date:  2020-12

2.  A Recent Human Immunodeficiency Virus Outbreak Among People Who Inject Drugs in Munich, Germany, Is Associated With Consumption of Synthetic Cathinones.

Authors:  Kirsten Hanke; Stefan Fiedler; Christina Grumann; Oliver Ratmann; Andrea Hauser; Patrycja Klink; Karolin Meixenberger; Britta Altmann; Ruth Zimmermann; Ulrich Marcus; Viviane Bremer; Volker Auwärter; Norbert Bannert
Journal:  Open Forum Infect Dis       Date:  2020-05-27       Impact factor: 3.835

3.  Univariable associations between a history of incarceration and HIV and HCV prevalence among people who inject drugs across 17 countries in Europe 2006 to 2020 - is the precautionary principle applicable?

Authors:  Lucas Wiessing; Eleni Kalamara; Jack Stone; Peyman Altan; Luk Van Baelen; Anastasios Fotiou; D'Jamila Garcia; Joao Goulao; Bruno Guarita; Vivian Hope; Marie Jauffret-Roustide; Lina Jurgelaitienė; Martin Kåberg; Adeeba Kamarulzaman; Liis Lemsalu; Anda Kivite-Urtane; Branko Kolarić; Linda Montanari; Magdalena Rosińska; Lavinius Sava; Ilonka Horváth; Thomas Seyler; Vana Sypsa; Anna Tarján; Ioanna Yiasemi; Ruth Zimmermann; Marica Ferri; Kate Dolan; Anneli Uusküla; Peter Vickerman
Journal:  Euro Surveill       Date:  2021-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.